It is possible that activation of the Ras/Raf/MEK/ERK and Ras/PI3K/PTEN/Akt/mTOR survival pathways by additional mutations in upstream oncogenes may replace the tumor's initial oncogene addition. Here, RAF1 is linked to neoplasm.